-

Granular Insurance Company (previously Coefficient Insurance Company), Verily, and Swiss Re Corporate Solutions Close Investment Transaction

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Coefficient, the precision risk company created by Verily, reported today that its previously announced transaction, which included an investment by Swiss Re Corporate Solutions, has successfully closed. In addition, the company concurrently unveiled a refreshed brand and company name, Granular Insurance. The new company name and associated brand capture the unique values of the company’s precision risk business model and the “granular” framework for predictability over the multi-year relationships it facilitates.

“We’re thrilled to officially welcome Swiss Re Corporate Solutions as a strategic investor as we enter this next chapter of the company’s growth,” said Denny Weinberg, Chief Executive Officer of Granular Insurance. “The initial precision risk solution launch already supports employers with a combined enrollment of well over 100,000 consumers, a number we expect to grow significantly over the coming months.”

“Granular Insurance aligns with our goal to use data and technology to address industry inefficiencies and improve the customer experience,” said Ivan Gonzalez, CEO North America Swiss Re Corporate Solutions. “We’re excited to be a part of this collaboration and advance employer stop-loss together.”

In connection with this investment, Ivan Gonzalez, and Linda Mantia, former EVP of Manulife Financial Services and Royal Bank executive, have joined the Granular Insurance Company Board of Directors, which is chaired by Vivian Lee, MD, President of Health Platforms, Verily.

About Granular Insurance

Granular Insurance provides self-funded employers and other health care stakeholders with a new data-informed coverage model called precision risk that is intended to better manage risk volatility, more effectively balance insurance and self funded costs and achieve more predictable business outcomes. Investors in Granular Insurance are Verily Life Sciences LLC and Swiss Re Corporate Solutions, the commercial insurance unit of the Swiss Re Group. To learn more, visit http://granularinsurance.com.

Contacts

Robin Suchan
Public Affairs and Communications, Verily
Email: suchan@verily.com
Direct: 415-736-1547

Verily


Release Versions

Contacts

Robin Suchan
Public Affairs and Communications, Verily
Email: suchan@verily.com
Direct: 415-736-1547

More News From Verily

Mayo Clinic, Verily to Build Advanced Clinical Decision Support to Enhance Care

ROCHESTER, Minn.--(BUSINESS WIRE)--Mayo Clinic and Verily, an Alphabet company founded at the convergence of health care, data science and technology, today announced a strategic two-year collaboration. This collaboration focuses on the development of a digital point-of-care resource of vetted knowledge to support an individualized approach to patient care. This modular, evidence-based decision support solution, will provide contextualized and validated knowledge on disease management, care gui...

Verily to Acquire SignalPath, Expanding Company’s Clinical Research Capabilities

SOUTH SAN FRANCISCO, Calif. & RALEIGH, N.C.--(BUSINESS WIRE)--Verily, an Alphabet company, and SignalPath today announced that they have entered into an agreement in which Verily will acquire SignalPath, a privately held company based in Raleigh that has developed the SignalPath platform, a clinical trial management system (CTMS) that improves the ease, quality and efficiency of conducting clinical research at study sites. “Joining forces helps to accelerate and scale our shared vision, increas...

Colgate-Palmolive to Leverage Verily’s Baseline Platform for Innovative Study in Oral Health Research

SOUTH SAN FRANCISCO, Calif. & NEW YORK--(BUSINESS WIRE)--Verily, an Alphabet company, and Colgate-Palmolive, the global leader in oral care, today announced a strategic collaboration to advance oral health research. Under the agreement, Colgate's Dental Clinical Team will partner with Verily to conduct an innovative oral health study as part of Verily’s ongoing Baseline Health Study that will aim to improve understanding of connections between oral health and overall human health. The study’s g...
Back to Newsroom